This is to notify all that we have begun joint clinical research into nematode cancer detection (N-NOSE) of primary hepatic cancer, together with Tokyo University.
Regarding N-NOSE, both parties are considering whether it is possible to predict the effects of surgery, postoperative recurrence, and the prognosis by evaluating and reviewing the treatment of primary hepatic cancer and the progress following said treatment.
HIROTSU Bioscience Inc. (Head Office: Chiyoda-ku, Tokyo, Representative: Takaaki Hirotsu, hereinafter referred to as “HIROTSU) has verified the . . .
2024.02.29HIROTSU Bio Science Inc. (Head Office: Chiyoda-ku, Tokyo; Representative Director: Takaaki Hirotsu; hereinafter referred to as "HIROTSU") has su . . .
2024.02.20We as HIROTSU Bio Science Inc. (Head Office: Chiyoda-ku, Tokyo; Representative: Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”) are pleas . . .
2023.12.21